| Identification | Back Directory | [Name]
2,7b-Diazabenzo[f]cycloprop[cd]indene-4,7-dione, 3-[[(aminocarbonyl)oxy]methyl]-1,2,2a,3,7c,7d-hexahydro-2a,5-dimethoxy-6-methyl-, (2aR,3S,7cS,7dS)- (9CI) | [CAS]
91917-64-5 | [Synonyms]
Isomitomycin A
2,7b-Diazabenzo[f]cycloprop[cd]indene-4,7-dione, 3-[[(aminocarbonyl)oxy]methyl]-1,2,2a,3,7c,7d-hexahydro-2a,5-dimethoxy-6-methyl-, (2aR,3S,7cS,7dS)- (9CI) | [Molecular Formula]
C16H19N3O6 | [MOL File]
91917-64-5.mol | [Molecular Weight]
349.34 |
| Hazard Information | Back Directory | [Uses]
Isomitomycin A is a potential inhibitor against SARS-CoV-2. Isomitomycin A targets to the hACE2 binding site of the modelled surface glycoprotein of SARS-CoV-2. Isomitomycin A can be used in studies of COVID-19[1]. | [References]
[1] Basak H K, et al. Sequence Analysis, Structure Prediction of Receptor Proteins and In Silico Study of Potential Inhibitors for Management of Life Threatening COVID-19[J]. Letters in Drug Design & Discovery, 2022, 19(2): 108-122. |
|
|